Literature DB >> 30868340

Expression of Slc35f1 in the murine brain.

Jacob Farenholtz1, Nadine Artelt1, Antje Blumenthal1, Karlhans Endlich1, Heyo K Kroemer2, Nicole Endlich1, Oliver von Bohlen Und Halbach3.   

Abstract

The solute carrier (SLC) group of membrane transport proteins includes about 400 members organized into more than 50 families. The SLC family that comprises nucleoside-sugar transporters is referred to as SLC35. One of the members of this family is SLC35F1. The function of SLC35F1 is still unknown; however, recent studies demonstrated that SLC35F1 mRNA is highly expressed in the brain and in the kidney. Therefore, we examine the distribution of Slc35f1 protein in the murine forebrain using immunohistochemistry. We could demonstrate that Slc35f1 is highly expressed in the adult mouse brain in a variety of different brain structures, including the cortex, hippocampus, amygdala, thalamus, basal ganglia, and hypothalamus. To examine the possible roles of Slc35f1 and its subcellular localization, we used an in vitro glioblastoma cell line expressing Slc35f1. Co-labeling experiments were performed to reveal the subcellular localization of Slc35f1. Our results indicate that Slc35f1 neither co-localizes with markers for the Golgi apparatus nor with markers for the endoplasmic reticulum. Time-lapse microscopy of living cells revealed that Slc35f1-positive structures are highly dynamic and resemble vesicles. Using super-resolution microscopy, these Slc35f1-positive spots clearly co-localize with the recycling endosome marker Rab11.

Entities:  

Keywords:  Central nervous system; Neuron; Rab; Slc35

Mesh:

Substances:

Year:  2019        PMID: 30868340     DOI: 10.1007/s00441-019-03008-8

Source DB:  PubMed          Journal:  Cell Tissue Res        ISSN: 0302-766X            Impact factor:   5.249


  1 in total

1.  SLC35F1 as a candidate gene for neurodevelopmental disorders resembling Rett syndrome.

Authors:  Elisabetta Di Fede; Angela Peron; Elisa Adele Colombo; Cristina Gervasini; Aglaia Vignoli
Journal:  Am J Med Genet A       Date:  2021-04-05       Impact factor: 2.802

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.